7 October 2024 in Obstetrics, Gynecology and Reproduction
Early-onset neonatal sepsis (EОNS) is one of the most severe diseases of the neonatal period and is often coupled to extremely unfavorable outcomes. In many ways, the severity of the condition and the results of newborn nursing depend on the etiology of the bacterial process. The major EОNS pathogens are traditionally considered to be Streptococcus group B and E. coli, much less common are other Gram-negative bacteria including casuistic cases caused by caused by Proteus mirabilis (P. mirabilis). The article provides a review on the P. mirabilis role in developing neonatal sepsis with pathogen-specific disease course and outcomes. In addition, we describe a clinical case of P. mirabilis-caused EОNS not only primarily characterized by the rarity of its causative agent, but also that it proceeded with a more favorable brain damage in contrast to similar cases described worldwide and because the neonatal EОNS developed in one of triplets, with two other babies being asymptomatic despite that P. mirabilis was also detected.
23 July 2024 in Obstetrics, Gynecology and Reproduction
Here, we review the latest available studies on using surfactant lavage in newborns with severe manifestations of meconium aspiration syndrome (MAS), illustrated by a representative clinical case. Meconium-stained amniotic fluid may be found in 8-20 % of all births, with the incidence reaching 23-52 % after a full 42 weeks of gestation. From 2 to 9 % of newborns with meconium-stained amniotic fluid subsequently develop MAS clinical signs. About a third of newborns with MAS require tracheal intubation and mechanical ventilation. MAS-related mortality rate due to severe injuries of the lung parenchyma and the development of pulmonary hypertension, can exceed 20 %. Other complications, including air leak syndrome (ALS), occur in 10-30 % of children with MAS. Surfactant lavage may be one of the clinical tools that avoids extracorporeal membrane oxygenation (ECMO) in severe MAS cases. This clinical observation is also of interest because a mature, even post-term newborn with MAS subsequently developed a typical bronchopulmonary dysplasia (BPD), which required proper treatment.
12 November 2025 in Obstetrics, Gynecology and Reproduction
Neonatal human herpesvirus type 6 (HHV-6) infection is an extremely rare disease. HHV-6 is a unique virus because it is able to integrate into human chromosomes to be further transmitted vertically from parent to offspring. In humans, HHV-6 is associated with a wide range of clinical manifestations and, in children, may present as roseola infantum, febrile seizures, aphthous stomatitis, mononucleosis-like syndrome, or fever of unknown origin. This article reports a rare case of congenital HHV-6 infection in a newborn. To date, both Russian and international publications provide very limited descriptions of such cases, which, in our opinion, reflects a significant knowledge gap among neonatologists regarding this condition. We discuss the clinical forms of HHV-6 infection in neonates, rare case presentations, and current approaches to diagnosis and treatment.
25 April 2026 in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
Early microbial colonization influences the risk of congenital infections during the neonatal period. The aim. To assess the spectrum and frequency of primary microbial colonization in conditionally healthy term and late preterm newborns at risk for early-onset neonatal sepsis (EONS) immediately after birth, and to determine the clinical significance of the identified pathogens. Materials and Methods. A prospective single-center study (City Clinical Hospital No. 67, Moscow, September 2024 — March 2025) included 705 newborns (GA 35–42 weeks). Bacteriological samples were collected immediately after birth from two non-sterile sites — the nasopharynx and anus. A total of 1407 cultures were obtained. Microorganisms were identified using mass spectrometry. Results. Bacterial growth was detected in 14.4 % (nasopharynx) and 16.8 % (anus) of healthy full-term and late preterm newborns. Fifteen genera were identified; Gram-positive cocci predominated (22.3 %), while Gram-negative bacteria were less common (6.5 %). The dominant species were Streptococcus agalactiae, Escherichia coli, Staphylococcus epidermidis, and Enterococcus faecalis. Vaginal delivery was associated with a higher frequency of S. epidermidis colonization (6.8% vs 1.6%; p=0.006). Conclusion. Screening of cultures from non-sterile sites in apparently healthy newborns may serve as an accessible tool for early risk stratification of EONS.
22 February 2024 in Pediatria. Journal named after G.N. Speransky
Purpose of the research was to evaluate the effect of the administration of epoetin alfa (Eralfon®️) after 8 days of life in very preterm infants with birthweight below 1500 gram and gestational age below 310/7 weeks on the anemia of prematurity, on hemoglobin levels in blood at the age of six months and on retinopathy of prematurity. Materials and methods used: a retrospective study of 105 very preterm infants was conducted at the two perinatal centers, L.A. Vorokhobov Moscow City Clinical Hospital No. 67 of the Moscow Department of Healthcare (Moscow, Russia) and Yaroslavl Oblast Regional Perinatal Center (Yaroslavl, Russia), who were divided into two groups, G1 (56) who did not receive epoetin alpha (EA) at 1 to 2 months of life (the so-called “no EA Group”) and were nursed at the Yaroslavl Oblast Regional Perinatal Center; and G2 (49) who received EA at 1 to 2 months of life (the “EA Group”) and were nursed at the L.A. Vorokhobov Moscow City Clinical Hospital No. 67 of the Moscow Department of Healthcare. In the “EA Group,” there was late (after the 8th day of life) EA administration at a dose of 200 units/kg at once subcutaneously 3 times per week for 6 weeks. Results: hemoglobin levels in peripheral blood on the first day of life had no statistically significant differences. The level of hemoglobin in peripheral blood at the age of 6 months was statistically significantly higher in preterm infants who had received EA at 1 to 2 months of life. The development of the anemia of prematurity was statistically significantly less frequently recorded in the “EA Group:” 40 out of 49 (82.0%) vs. 54 out of 56 (96.0%), p=0.022. Erythrocyte transfusion in the “no EA Group” was performed in 38 out of 56 (67.8%), 25 out of 49 (51.0%) in the “EA group,” p=0.079, OR 0.49 [0.22, 1.08], RR 0.71 [0.47, 1.06]. Children who were in need of high-frequency oscillatory ventilation (HFOV) have not only had statistically significantly more frequent need for erythrocyte transfusion but also statistically significantly more often developed BPD and retinopathy of prematurity at the stage that requires surgical intervention. Conclusion: late EA administration in preterm infants with birthweight below 1500 gram reduces the risk of the development of the anemia of prematurity, increases the level of hemoglobin in peripheral blood at the age of six months old and does not increase the risk for development of retinopathy of prematurity.